Confident Investing Starts With TipRanks Premium

Get 55% Off
TipRanks
Go Ultimate55% OFF

Renalytix (RNLXY) Stock Price & Analysis

RNLXY Stock Chart & Stats

$3.65-$0.05(-1.30%)
At close: 4:00 PM EST
$2$3$410 Aug24 Aug8 Sep21 Sep5 Oct19 Oct2 Nov
Day’s Range
$3.65 - $3.65
52-Week Range
$1.00 - $5.56
Previous Close
$3.70
Volume
N/A
Average Volume (3M)
3,382
Market Cap
$48.97M
Enterprise Value
$16.54M
Total Cash (Recent Filing)
N/A
Total Debt (Recent Filing)
N/A
Price to Earnings (P/E)
―
Beta
0.89
Next Earnings
Dec 08, 2026 (Est.)
EPS Estimate
N/A
Next Dividend Ex-Date
N/A
Dividend Yield
N/A

Bulls Say, Bears Say

Bulls Say

Innovative Product Offering

Renalytix's use of machine learning in diagnostics positions it as a leader in innovative kidney disease management, potentially driving long-term growth.

Strategic Partnerships

Strategic collaborations expand market reach and enhance technology adoption, providing diversified revenue streams and long-term business stability.

Revenue Model

The recurring revenue model from testing fees ensures a steady income stream, supporting financial sustainability and growth potential.

Bears Say

Financial Distress

Ongoing financial distress with negative equity and losses threatens long-term viability, requiring urgent strategic restructuring for recovery.

Negative Cash Flow

Negative cash flow indicates liquidity issues, limiting operational flexibility and the ability to invest in growth opportunities, impacting long-term prospects.

Declining Revenue

Consistent revenue decline reflects challenges in market penetration and product adoption, posing risks to sustainable growth and profitability.

Renalytix News

RNLXY FAQ

What was Renalytix’s price range in the past 12 months?
Renalytix lowest stock price was $1.00 and its highest was $5.56 in the past 12 months.
What is Renalytix’s market cap?
Renalytix’s market cap is $48.97M.
When is Renalytix’s upcoming earnings report date?
The company’s upcoming earnings report date is not yet available.
How were Renalytix’s earnings last quarter?
Renalytix released its earnings results on Oct 28, 2026. The company reported -$0.698 earnings per share for the quarter.
Is Renalytix overvalued?
Not enough analysts have published a price target to calculate whether the price is overvalued.
Does Renalytix pay dividends?
Renalytix does not currently pay dividends.
What is Renalytix’s EPS estimate?
Renalytix’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Renalytix have?
Renalytix has 13,409,186 shares outstanding.
What happened to Renalytix’s price movement after its last earnings report?
Renalytix reported an EPS of -$0.698 in its last earnings report. Following the earnings report the stock price went down -4.935%.
Which hedge fund is a major shareholder of Renalytix?
Hedge funds hold Renalytix shares: the largest hedge-fund position in Renalytix is 62,357,147 shares, and hedge funds decreased their holdings by 30.4K shares last quarter.
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology